EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells.

about

Smenamide A Analogues. Synthesis and Biological Activity on Multiple Myeloma Cells.

P2860

Q55455557-0EA9510D-FC88-4F05-B671-16281D4E36D1

P2860

EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells.

Item

http://www.wikidata.org/entity/Q51808808

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

EphA3 targeting reduces in vit ...... sis of multiple myeloma cells.

@en

EphA3 targeting reduces in vit ...... sis of multiple myeloma cells.

@nl

type

Item

label

EphA3 targeting reduces in vit ...... sis of multiple myeloma cells.

@en

EphA3 targeting reduces in vit ...... sis of multiple myeloma cells.

@nl

prefLabel

EphA3 targeting reduces in vit ...... sis of multiple myeloma cells.

@en

EphA3 targeting reduces in vit ...... sis of multiple myeloma cells.

@nl

P1476

EphA3 targeting reduces in vit ...... esis of multiple myeloma cells

@en

P2093

Daniela Cilloni

http://www.w3.org/2001/XMLSchema#string

Emma Di Carlo

http://www.w3.org/2001/XMLSchema#string

Fiorella D'Auria

http://www.w3.org/2001/XMLSchema#string

Katia Todoerti

http://www.w3.org/2001/XMLSchema#string

Luciana De Luca

http://www.w3.org/2001/XMLSchema#string

Luigi Del Vecchio

http://www.w3.org/2001/XMLSchema#string

Martin Lackmann

http://www.w3.org/2001/XMLSchema#string

Oreste Villani

http://www.w3.org/2001/XMLSchema#string

Pellegrino Musto

http://www.w3.org/2001/XMLSchema#string

Stefania Trino

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of HEK, the gene encoding a receptor tyrosine kinase expressed by human lymphoid tumor cell lines

Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives

Molecular Classification and Pharmacogenetics of Primary Plasma Cell Leukemia: An Initial Approach toward Precision Medicine

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma

Eph-ephrin bidirectional signaling in physiology and disease

CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.

Dissecting the EphA3/Ephrin-A5 interactions using a novel functional mutagenesis screen.

Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia.

Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.

A high affinity recombinant antibody to the human EphA3 receptor with enhanced ADCC activity.

P2888

s13402-017-0338-4

P304

483-496

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13402-017-0338-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28721629

http://www.w3.org/2001/XMLSchema#string

EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells.

about

P2860

P2860

EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698